<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Chin Med J (Engl)</journal-id><journal-id journal-id-type="iso-abbrev">Chin. Med. J</journal-id><journal-id journal-id-type="publisher-id">CMJ</journal-id><journal-title-group><journal-title>Chinese Medical Journal</journal-title></journal-title-group><issn pub-type="ppub">0366-6999</issn><publisher><publisher-name>Medknow Publications &#x00026; Media Pvt Ltd</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28469108</article-id><article-id pub-id-type="pmc">5421183</article-id><article-id pub-id-type="publisher-id">CMJ-130-1113</article-id><article-id pub-id-type="doi">10.4103/0366-6999.204931</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>Vascular Calcification: Current Genetics Underlying This Complex Phenomenon</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>P&#x000e9;rez-Hern&#x000e1;ndez</surname><given-names>Nonanzit</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Aptilon-Duque</surname><given-names>Gad</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Blachman-Braun</surname><given-names>Ruben</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Vargas-Alarc&#x000f3;n</surname><given-names>Gilberto</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Rodr&#x000ed;guez-Cort&#x000e9;s</surname><given-names>Adri&#x000e1;n Asael</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Azrad-Daniel</surname><given-names>Shely</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Posadas-S&#x000e1;nchez</surname><given-names>Rosalinda</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Rodr&#x000ed;guez-P&#x000e9;rez</surname><given-names>Jos&#x000e9; Manuel</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1"/></contrib></contrib-group><aff id="aff1"><label>1</label>Department of Molecular Biology, National Institute of Cardiology &#x0201c;Ignacio Ch&#x000e1;vez&#x0201d;, M&#x000e9;xico, Mexico City 14080, M&#x000e9;xico</aff><aff id="aff2"><label>2</label>Department of Endocrinology, National Institute of Cardiology &#x0201c;Ignacio Ch&#x000e1;vez&#x0201d;, M&#x000e9;xico, M&#x000e9;xico City 14080, M&#x000e9;xico</aff><author-notes><corresp id="cor1"><bold>Address for correspondence:</bold> Dr. Jos&#x000e9; Manuel Rodr&#x000ed;guez-P&#x000e9;rez, Department of Molecular Biology, National Institute of Cardiology &#x0201c;Ignacio Ch&#x000e1;vez&#x0201d;, Juan Badiano No. 1, Col. Secci&#x000f3;n XVI, Tlalpan 14080, Mexico City, Mexico E-Mail: <email xlink:href="josemanuel_rodriguezperez@yahoo.com.mx">josemanuel_rodriguezperez@yahoo.com.mx</email></corresp></author-notes><pub-date pub-type="ppub"><day>05</day><month>5</month><year>2017</year></pub-date><volume>130</volume><issue>9</issue><fpage>1113</fpage><lpage>1121</lpage><history><date date-type="received"><day>16</day><month>12</month><year>2016</year></date></history><permissions><copyright-statement>Copyright: &#x000a9; 2017 Chinese Medical Journal</copyright-statement><copyright-year>2017</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.</license-p></license></permissions><abstract><sec id="st1"><title>Objective:</title><p>Vascular calcification is the consequence of the complex interaction between genetic, environmental, and vascular factors, which ultimately lead to the deposition of calcium in the <italic>tunica intima</italic> (atherosclerotic calcification) or <italic>tunica media</italic> (M&#x000f6;nckenberg's sclerosis). Vascular calcification is also closely related to other pathologies, such as diabetes mellitus, dyslipidemia, and chronic kidney disease. It has been concluded that the degree of vascular calcification may vary from person to person, even if the associated pathologies and environmental factors are the same. Therefore, this suggests an important genetic contribution to the development of vascular calcification. This review aimed to find the most recent evidence about vascular calcification pathophysiology regarding the genetic aspects and molecular pathways.</p></sec><sec id="st2"><title>Data Sources:</title><p>We conducted an exhaustive search in Scopus, EBSCO, and PubMed with the keywords &#x0201c;genetics and vascular calcification&#x0201d;, &#x0201c;molecular pathways, genetic and vascular calcification&#x0201d; and included the main articles from January 1995 up to August 2016. We focused on the most recent evidence about vascular calcification pathophysiology regarding the genetic aspects and molecular pathways.</p></sec><sec id="st3"><title>Study Selection:</title><p>The most valuable published original and review articles related to our objective were selected.</p></sec><sec id="st4"><title>Results:</title><p>Vascular calcification is a multifactorial disease; thus, its pathophysiology cannot be explained by a single specific factor, rather than by the result of the association of several genetic variants, molecular pathway interactions, and environmental factors that promote its development.</p></sec><sec id="st5"><title>Conclusion:</title><p>Although several molecular aspects of this mechanism have been elucidated, there is still a need for a better understanding of the factors that predispose to this disease.</p></sec></abstract><kwd-group><kwd>Atherosclerosis</kwd><kwd>Cardiovascular Risk</kwd><kwd>Genetics</kwd><kwd>Polymorphisms</kwd><kwd>Vascular Calcification</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-1"><title>I<sc>ntroduction</sc></title><p>Calcium phosphate, in the form of hydroxyapatite (Ca<sub>10</sub>(PO<sub>4</sub>)<sub>6</sub>(OH)<sub>2</sub>), is the main inorganic component of the bony tissue. Its crystals grow from vesicles secreted by osteoblasts and function as major nests of bony tissue formation.[<xref rid="ref1" ref-type="bibr">1</xref>] Vascular smooth muscle cells can similarly secrete these vesicles, promoting ectopic formation of bony tissue and creating what it is generally known as vascular calcification.[<xref rid="ref2" ref-type="bibr">2</xref>]</p><p>Vascular calcification is the result of a deregulated mineral metabolism, which ultimately leads to hydroxyapatite deposits on the vascular wall. It has been reported that vascular calcification prevalence increases with age. Moreover, when pathologies such as diabetes mellitus, dyslipidemia, hypertension, and chronic kidney disease (CKD) are present, the mechanisms that inhibit the deposition hydroxyapatite crystals at the vascular level are prone to be affected.[<xref rid="ref3" ref-type="bibr">3</xref><xref rid="ref4" ref-type="bibr">4</xref>] Therefore, in the last 20 years, the perception of vascular calcification as a pathology evoked by a passive consequence of aging has changed to the concept of an active phenomenon, in which hemodynamical, pathological, anatomical, genetic, and epigenetic factors interact to facilitate calcium deposition at the vascular level.[<xref rid="ref5" ref-type="bibr">5</xref>]</p><p>Vascular calcification is an inherent phenomenon, as ancient as the human species. Historically, ancient civilizations also suffered from this pathology. In fact, computed tomography (CT) scans of mummies from the Egyptian empire show high prevalence of calcium phosphate deposits affecting coronary, carotid, iliac, femoral, and aorta arteries.[<xref rid="ref6" ref-type="bibr">6</xref>]</p><p>From the histological standpoint, there are two types of vascular calcification. The first is the calcification of the <italic>tunica intima</italic>, also known as atherosclerotic calcification, while the second is the calcification of the <italic>tunica media</italic> or M&#x000f6;nckenberg's sclerosis.[<xref rid="ref3" ref-type="bibr">3</xref>] Although studies have found that atherosclerotic calcification has a higher association with a chronic vascular inflammatory process than the M&#x000f6;nckenberg's sclerosis, this has not been completely proven in genetic and image trials aiming to define their underlying mechanisms. As a consequence, it is established that it is difficult to discriminate between these two phenomena. Further, both of these entities might share some of the same pathophysiological pathways.[<xref rid="ref7" ref-type="bibr">7</xref>]</p><p>The presence of vascular calcification catalyzes the deposition of new ectopic calcium in large amounts,[<xref rid="ref3" ref-type="bibr">3</xref>] increasing the risks for other cardiovascular diseases and adverse cardiovascular effects.[<xref rid="ref8" ref-type="bibr">8</xref>]</p><p>Moreover, the linkage between vascular calcification and genetics has been confirmed by a multiethnic study, which aimed to understand the genetic basis of atherosclerosis. In this study, an association was found between familial coronary disease and the prevalence of coronary artery calcification (CAC). These results were consistent in all ethnic groups. In addition, this study revealed a high hereditable component for both coronary artery and abdominal aorta calcification.[<xref rid="ref9" ref-type="bibr">9</xref>]</p><p>In this article, we have taken into account the different aspects in which the genetic and molecular pathways are presumably involved with vascular calcification. Consequently, this review is directed to physicians and its aim is to elucidate the different associations and mechanisms that predispose to vascular calcification with a genetics scope. In addition, a brief discussion of its clinical approach in the diagnosis and treatment has been incorporated into this work.</p></sec><sec id="sec1-2"><title>G<sc>enetics</sc></title><p>The etiology of vascular calcification is multifactorial. It has been well defined that genetics plays a pivotal role in the pathogenesis of this disease. Indeed, studies have associated up to 50% of the components of this pathological entity to heredity.[<xref rid="ref7" ref-type="bibr">7</xref>] In the human genome, multiple loci have been associated with the presence of CAC and atherosclerosis.[<xref rid="ref3" ref-type="bibr">3</xref>]</p><p>Studies have reported a risk allele of a single-nucleotide polymorphism (SNP) in chromosome 9p21.3, in which the cyclin-dependent kinase inhibitor (<italic>CDKN2A</italic> and <italic>CDKN2B</italic>)genes are located. The genetic variants located in both genes (<italic>CDKN2A</italic> and <italic>CDKN2B</italic>) increase the risk for both CAC and premature atherosclerosis, suggesting that the presence of polymorphisms in this gene sequence affects the normal modulation of vascular smooth muscle cell proliferation.[<xref rid="ref10" ref-type="bibr">10</xref><xref rid="ref11" ref-type="bibr">11</xref>] As a consequence, this causes vascular calcification, which will be explained below. In addition, other SNPs associated with CAC are located in region 6p24, within the phosphate and actin regulator 1 gene.[<xref rid="ref3" ref-type="bibr">3</xref><xref rid="ref11" ref-type="bibr">11</xref><xref rid="ref12" ref-type="bibr">12</xref>] A genomic hypertension study also associates regions 6p21.3 and 10q21.3 to CAC.[<xref rid="ref7" ref-type="bibr">7</xref><xref rid="ref13" ref-type="bibr">13</xref>]</p><p>The current state of knowledge cannot completely explain the mechanism by which the different genomic variants may affect the genetic expression, posttranscriptional modifications (e.g., alternative splicing), or peptide sequence, which ultimately modulate vascular calcification. According to the genetic and physiological influences, other genes have been suggested as possible causative agents. In addition, other polymorphisms with possible associations with vascular calcification have been found. These genes have been grouped according to their mechanism of action in different categories [<xref ref-type="table" rid="T1">Table 1</xref>]. Furthermore, polymorphism studies have reported conflicting data on the aforementioned genes; in other words, both positive evidence and negative evidence regarding their association with vascular calcification have been published. Therefore, no conclusions should be drawn on this matter at the moment.[<xref rid="ref7" ref-type="bibr">7</xref>]</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Genes associated with vascular calcification grouped according to their mechanism of action</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Category</th><th align="left" rowspan="1" colspan="1">Gene</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Influence on endothelial function and leukocyte adhesion</td><td align="left" rowspan="1" colspan="1"><italic>CCR2</italic></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><italic>ACE</italic></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><italic>ELAM-1</italic></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><italic>EPHX2</italic></td></tr><tr><td align="left" rowspan="1" colspan="1">Oxidative stress modulation</td><td align="left" rowspan="1" colspan="1"><italic>GPx-1</italic></td></tr><tr><td align="left" rowspan="1" colspan="1">Extracellular matrix remodeling</td><td align="left" rowspan="1" colspan="1"><italic>MMP3</italic></td></tr><tr><td align="left" rowspan="1" colspan="1">Bone metabolism</td><td align="left" rowspan="1" colspan="1"><italic>BMP</italic></td></tr><tr><td align="left" rowspan="1" colspan="1">Vitamin K metabolism</td><td align="left" rowspan="1" colspan="1"><italic>MGP</italic></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><italic>CALU</italic></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><italic>VKORC1</italic></td></tr></tbody></table><table-wrap-foot><fn><p><italic>CCR2</italic>: Chemokine receptor type 2; <italic>ACE</italic>: Angiotensin-converting enzyme; <italic>ELAM-1</italic>: Endothelial leukocyte adhesion molecule 1, or E-selectin; <italic>EPHX2</italic>: Epoxide hydrolase 2; <italic>GPx-1</italic>: Glutathione peroxidase 1; <italic>MMP3</italic>: Matrix metalloproteinase 3; <italic>BMP</italic>: Bone morphogenetic protein; <italic>MGP</italic>: Matrix Gla Protein; <italic>CALU</italic>: Calumenin; <italic>VKORC1</italic>: Vitamin K epoxide reductase complex subunit 1.</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec1-3"><title>P<sc>athophysiology</sc></title><p>Broadly speaking, two major pathophysiological pathways explain the origins of ectopic calcification, namely the unregulated induction of osteogenesis and second, the loss of mineralization inhibition factors.</p><sec id="sec2-1"><title>Unregulated induction of osteogenesis</title><p>Smooth muscle cell differentiation to bony tissue can be induced through different pathways. As discussed below, oxidative stress, endothelial dysfunction, and proinflammatory factors play a major role in this differentiation.</p><p><bold>Onset of vascular osteogenesis</bold></p><p>Calcifying cells, a subfamily of vascular smooth muscle cells, establish an important role in the aforementioned process.[<xref rid="ref14" ref-type="bibr">14</xref>] In <italic>in vitro</italic> studies, calcifying nodules have been observed within these cells, sharing important characteristics with bony tissue, such as increased activity of alkaline phosphatase (ALP) and expression of osteopontin (OPN), osteonectin, and osteocalcin.[<xref rid="ref15" ref-type="bibr">15</xref>] In addition, calcifying cells represent up to 20% of the vascular smooth muscle cell population, and can potentially generate a mesenchymal lineage of osteoblasts, promoting osteogenesis.[<xref rid="ref2" ref-type="bibr">2</xref>]</p><p>Alternatively, pericytes are another kind of vascular osteogenic inductor &#x02013; a group of contractile cells that surround the endothelial cells in the capillaries. These cells have a high potential to become mesenchymal progenitors and differentiate into osteoblasts and chondrocytes.[<xref rid="ref16" ref-type="bibr">16</xref>] In addition, pericytes adopt a behavior similar to calcifying cells by generating <italic>in vitro</italic> calcified nodules,[<xref rid="ref17" ref-type="bibr">17</xref>] presenting molecules such as type I collagen, OPN, matrix Gla protein (MGP),[<xref rid="ref18" ref-type="bibr">18</xref>] and osteocalcin within the vasculature. When an atherosclerotic lesion is present, these factors act as osteoprogenitors in the vascular wall. Moreover, pericytes are part of the microvasculature endothelium, and so, they are deeply involved in angiogenesis,[<xref rid="ref19" ref-type="bibr">19</xref>] which is closely related to vascular calcification as explained below.</p><p>The formation of new small intravascular blood vessels (angiogenesis) is common around vascular calcium deposits. In fact, the larger the calcified lesion is, the higher the level of angiogenesis will be found. However, the new vessels are prone to bleed within the plaque, which can ultimately lead to plaque disruption and ischemic events.[<xref rid="ref20" ref-type="bibr">20</xref>] Concerning this process, we can thus say that the greater the number of blood vessels, the higher the input of circulating factors that will potentially initiate calcification. Pericytes and calcifying cells can differentiate into osteoblasts too, which, in addition to their physiologic osteogenic role, can produce vascular endothelial growth factor. In turn, this promotes angiogenesis and creates the particular pathways essential for vascular calcification.[<xref rid="ref5" ref-type="bibr">5</xref>]</p><p><bold>Oxidative stress and cytokines</bold></p><p>Bone morphogenetic protein (BMP) molecules are known for their ectopic bone formation and are recognized as important mediators of vascular calcification. BMP2 and 4 favor mineralization while BMP7 has demonstrated its ability to retard this process.[<xref rid="ref21" ref-type="bibr">21</xref><xref rid="ref22" ref-type="bibr">22</xref>] BMP2 and 4 act primarily through the interaction with their receptors, which phosphorylate regulatory Smads (intracellular proteins that transduce extracellular signals and carry ligands to the nucleus where they activate a pathway of genetic transcription)[<xref rid="ref23" ref-type="bibr">23</xref><xref rid="ref24" ref-type="bibr">24</xref><xref rid="ref25" ref-type="bibr">25</xref>] and modulate genetic expression, thus favoring vascular calcification.[<xref rid="ref26" ref-type="bibr">26</xref>] On the other hand, BMP7 regulates expression of smooth muscle &#x003b1;-actin, preventing the osteoblastic differentiation.[<xref rid="ref21" ref-type="bibr">21</xref>] By the same token, it is suggested that polymorphisms in the <italic>BMP7</italic> gene are associated with a higher vascular calcification risk.[<xref rid="ref27" ref-type="bibr">27</xref>]</p><p>While BMPs have shown to be important mediators of calcifying processes, their effects are insufficient by themselves to create a calcified environment. To achieve calcification, a subsequent activation of other osteogenic transcription factors is needed. The main example of such molecules is the core-binding factor-&#x003b1;1 (Cbfa1).</p><p>Cbfa1 is a key element in the physiological osteoblastic differentiation. However, its function is not limited to bony tissue maturation. As a matter of fact, its expression in the vascular wall serves as a definite marker in the ectopic calcium deposits, generating the very first step in vascular calcification.[<xref rid="ref5" ref-type="bibr">5</xref>] Cbfa1 further activates osterix, which will influence the vascular calcification phenotype. Cbfa1 also controls the expression of several other proteins that will promote ectopic osteoblastic differentiation, such as osteocalcin, OPN, and type I collagen.[<xref rid="ref28" ref-type="bibr">28</xref><xref rid="ref29" ref-type="bibr">29</xref>]</p><p>As for these molecular pathways, high expression of BMP2 is observed when endothelial cells are exposed to free radicals,[<xref rid="ref30" ref-type="bibr">30</xref>] indicating that BMP2 expression is mediated by oxidative stress. For this reason, reactive oxygen species (ROS) can further incite other markers of vascular calcification, such as ALP activity.[<xref rid="ref31" ref-type="bibr">31</xref><xref rid="ref32" ref-type="bibr">32</xref><xref rid="ref33" ref-type="bibr">33</xref>]</p><p>BMP2 induces cyclooxygenase 2 activity and, as a result, it stimulates both prostaglandin production and nicotinamide adenine dinucleotide phosphate-oxidase oxidase subunit nox1 expression, which increases ROS formation. The role of BMP2 over the ROS regulation consequently provides an important link between vascular calcification and the inflammatory process, which is associated with endothelial dysfunction.[<xref rid="ref32" ref-type="bibr">32</xref>] Hence, both proinflammatory microenvironment and vascular calcification coexist in atherosclerotic lesions.[<xref rid="ref5" ref-type="bibr">5</xref>]</p><p>Inorganic phosphate can also activate Cbfa1. In fact, vascular cellular culture studies have been carried out with the intention to describe the effect of Cbfa1 over osteoblastic differentiation, and they have reported an induced mineralization and OPN expression after inorganic phosphate was added.[<xref rid="ref34" ref-type="bibr">34</xref><xref rid="ref35" ref-type="bibr">35</xref><xref rid="ref36" ref-type="bibr">36</xref>] This can be clinically related to the high presence of calcified plaques in patients with CKD,[<xref rid="ref34" ref-type="bibr">34</xref><xref rid="ref35" ref-type="bibr">35</xref>] who suffer from high levels of phosphate for two main reasons: poor glomerular filtration rate and, as a result, secondary hyperparathyroidism (a common complication of CKD). Accordingly, inorganic phosphate promotes osteoblastic phenotype through a type IIc sodium-dependent phosphate transporter that regulates calcium metabolism activating Cbfa1.[<xref rid="ref35" ref-type="bibr">35</xref><xref rid="ref36" ref-type="bibr">36</xref>] Alternatively, parathyroid hormone (PTH) is commonly elevated in patients with CKD and promotes the expression of protein kinase A, which can phosphorylate and activate Cbfa1.[<xref rid="ref37" ref-type="bibr">37</xref><xref rid="ref38" ref-type="bibr">38</xref>]</p><p>Recent evidence supports the essential role played by different proteins in the calcification of atherosclerotic lesions, such as OPN, OPG, receptor activator of nuclear factor-&#x003ba;B ligand (RANKL), and ALP. It has been indicated that serum OPG levels are associated with vascular calcification in humans. In addition, the determination of serum OPG has been suggested as a prognostic marker of cardiovascular disease. Chang <italic>et al</italic>. reported that a high concentration of glucose promotes the expression of OPG, and inhibits the expression of RANKL in vascular smooth muscle cells, a molecular pathway that could partially explain the mechanisms underlying diabetic vascular calcification.[<xref rid="ref39" ref-type="bibr">39</xref><xref rid="ref40" ref-type="bibr">40</xref><xref rid="ref41" ref-type="bibr">41</xref>]</p><p><bold>Medications implicated in calcification</bold></p><p>Warfarin, a Vitamin K antagonist, is commonly used as an oral anticoagulant to treat atherothrombotic diseases. Its use promotes vascular calcification by ultimately stopping gamma-carboxylation of MGP, an important inhibitory factor of calcification.[<xref rid="ref5" ref-type="bibr">5</xref>] By its mechanism of action, warfarin inhibits the expression of Vitamin K epoxide reductase complex subunit 1 gene, which is one of the candidate genes. This gene is responsible for converting Vitamin K epoxide into Vitamin K hydroquinone, an essential substrate for MGP carboxylation.[<xref rid="ref7" ref-type="bibr">7</xref>] When carboxylated MGP is absent, a procalcification environment is promoted.</p><p>Another molecule involved in vascular calcification is calcitriol (1,25-dihydroxyvitamin D), commonly used in secondary hyperparathyroidism. Especially in patients with CKD, high levels of Vitamin D can cause hypercalcemia, which then leads to a higher risk of soft-tissue calcification.[<xref rid="ref42" ref-type="bibr">42</xref>] Calcitriol increases ALP activity,[<xref rid="ref43" ref-type="bibr">43</xref>] and is physiologically inactivated by a chain reaction that starts with a hydroxylation reaction by 24-hydroxilase,[<xref rid="ref44" ref-type="bibr">44</xref>] an enzyme codified by cytochrome p450, family 24, subfamily A, polypeptide 1 (<italic>CYP24A1</italic>).[<xref rid="ref7" ref-type="bibr">7</xref>] Studies showed that <italic>CYP24A1</italic>-deficient mice indeed present excessively high levels of ectopic calcification.[<xref rid="ref45" ref-type="bibr">45</xref>] Hence, this result confirms that calcitriol is an enhancer of vascular calcification.</p><p><bold>Other osteogenic induction factors</bold></p><p>As previously mentioned, ALP activity is an important factor in the vascular calcification orchestra, because it serves as an early marker for the presence of calcium deposits. Since it is essential in the formation of hydroxyapatite during ossification, when this enzyme is active in other tissues, it indicates the initiation of ectopic ossification. ALP further modulates calcification by diminishing inorganic pyrophosphate levels, an important inhibitory factor of calcification.[<xref rid="ref46" ref-type="bibr">46</xref><xref rid="ref47" ref-type="bibr">47</xref>]</p><p>Leptin, another vascular calcification mediator, physiologically modulates bone mass, binding to and activating the ventromedial hypothalamic nucleus as well as &#x003b2;-adrenergic receptors in osteoblasts.[<xref rid="ref48" ref-type="bibr">48</xref><xref rid="ref49" ref-type="bibr">49</xref>] In <italic>in vitro</italic> models, it has been demonstrated that leptin plays a crucial role in vascular calcification. This occurs through mechanisms[<xref rid="ref50" ref-type="bibr">50</xref>] that promote osteoblast differentiation[<xref rid="ref51" ref-type="bibr">51</xref>] and increase oxidative stress in endothelial cells, which then induce the expression of BMP2, a well-known marker for vascular calcification.[<xref rid="ref52" ref-type="bibr">52</xref><xref rid="ref53" ref-type="bibr">53</xref>]</p></sec><sec id="sec2-2"><title>Loss of mineralization inhibition factor</title><p>As previously noted, the second pathophysiologic pathway present in vascular calcification refers to the loss or malfunction of the factors that, under normal circumstances, would inhibit calcification.</p><p><bold>Pyrophosphate pathway</bold></p><p>Under physiological conditions, calcium phosphate deposits in the vascular wall can trigger unfavorable reactions. Pyrophosphate is in charge of blocking the generation of these crystals, naturally inhibiting processes that lead to vascular calcification. Hence, it is suggested that vascular calcification is a consequence of pyrophosphate regulation alterations.[<xref rid="ref3" ref-type="bibr">3</xref>]</p><p>Associations between ectonucleotide pyrophosphatase/phosphodiesterase 1 (<italic>ENPP1</italic>) and idiopathic infantile arterial calcification have been well established. This gene codes for NPP1, an enzyme responsible for processing extracellular ATP (adenosine triphosphate), which then generates pyrophosphate. Thus, the loss of function of <italic>ENPP1</italic> is associated with autosomal recessive inheritance. This, in turn, results in a substantial decrease of serum pyrophosphate,[<xref rid="ref54" ref-type="bibr">54</xref><xref rid="ref55" ref-type="bibr">55</xref><xref rid="ref56" ref-type="bibr">56</xref>] promoting vascular calcification.</p><p>Another enzyme related to the pyrophosphate pathway is cluster of differentiation 73, a membrane surface protein coded by ecto-5&#x02019;-nucleotidase gene (<italic>NT5E</italic>). This enzyme catalyzes adenosine monophosphate conversion into inorganic phosphate, which makes it a calcification accelerator. Mutations in this gene are less severe and phenotypically not as restrictive as those in <italic>ENPP1</italic>. Nonetheless, it confirms the role of ATP derivative pyrophosphate pathway in vascular calcification from a genetic perspective.[<xref rid="ref57" ref-type="bibr">57</xref>]</p><p>Similarly, an additional mutation related to vascular calcification is present in ATP-binding cassette, subfamily C, member 6 (<italic>ABCC6</italic>),[<xref rid="ref58" ref-type="bibr">58</xref>] a gene that codes for a transmembrane ATP-dependent protein. Knockout mice models for this gene show the development of ectopic calcification in skin, retina, medium-sized arteries, aorta, and vena cava. Therefore, <italic>ABCC6</italic> gene is considered responsible for elastic pseudoxanthoma,[<xref rid="ref59" ref-type="bibr">59</xref>] a disease with the aforementioned characteristics, in addition to dystrophic calcinosis, which refers to calcium deposits in necrotic and inflamed spots.[<xref rid="ref60" ref-type="bibr">60</xref>] A molecular link between elastic pseudoxanthoma and vascular calcification is established on the clinical and histological similarities between the two, suggesting that they both arise through mutations in <italic>ABCC6</italic>, which affect the pyrophosphate pathway[<xref rid="ref61" ref-type="bibr">61</xref>] and reduce MGP gamma-carboxylation.[<xref rid="ref62" ref-type="bibr">62</xref>]</p><p><italic>ENPP1</italic> and <italic>NT5E</italic> interact with receptor of advanced glycation end products (RAGE),[<xref rid="ref63" ref-type="bibr">63</xref>] a receptor expressed on endothelial cells, macrophages, dendritic cells, and smooth muscle cells. When activated, the receptor initiates a signal cascade well evidenced to participate actively in vascular disease in general.[<xref rid="ref64" ref-type="bibr">64</xref><xref rid="ref65" ref-type="bibr">65</xref><xref rid="ref66" ref-type="bibr">66</xref><xref rid="ref67" ref-type="bibr">67</xref>] However, members of the S100 proteins family, RAGE ligands, also known as calgranulins, have been identified to interact specifically in the processes that lead to vascular calcification. A direct association has been made between the expression of the S100A12 protein, or calgranulin C, and vascular calcification in transgenic mice S100A12tg/ApoE deficient.[<xref rid="ref68" ref-type="bibr">68</xref><xref rid="ref69" ref-type="bibr">69</xref>] Vascular smooth muscle cells in those mice showed a rise in osteoblast genetic expression, as well as more calcium deposits.</p><p>Moreover, S100A8 (calgranulin A) and S100A9 (calgranulin B) both relate to ROS production.[<xref rid="ref70" ref-type="bibr">70</xref>] In addition, free radicals generate other reactions in the vasculature, including activation of RUNX-2: a regulator of osteoblast genetic expression.[<xref rid="ref71" ref-type="bibr">71</xref>] Besides, it is possible that S100 proteins may indirectly promote calcification through apoptotic mediators, creating necrotic bodies as potential calcification nests.[<xref rid="ref72" ref-type="bibr">72</xref>]</p><p><bold>Matrix Gla protein</bold></p><p>Its mechanism of action is complex; it modulates calcification by inhibiting the interaction between BMPs and their receptors.[<xref rid="ref73" ref-type="bibr">73</xref><xref rid="ref74" ref-type="bibr">74</xref><xref rid="ref75" ref-type="bibr">75</xref>] The variants in its serum levels regulate mineral deposition and osteogenic differentiation; while intermediate levels inhibit the process, both low and high levels may favor calcification.[<xref rid="ref74" ref-type="bibr">74</xref>]</p><p>To become functional, MGP needs to undergo &#x003b3;-carboxylation, and when it is carboxylated, MGP may bind to calcium. This causes conformational changes in the molecule, which will ultimately inhibit BMP interaction with its receptors, thus functioning as a physiologic inhibitor of calcification.[<xref rid="ref76" ref-type="bibr">76</xref><xref rid="ref77" ref-type="bibr">77</xref>] Note that when carboxylated, MGP inhibits calcification; however, this protein promotes calcification in its noncarboxylated form.</p><p><bold>Other inhibitory factors</bold></p><p>There is a great amount of other agents that inhibit vascular calcification; we will only mention a few of them. Similar to MGP, OPN and OPG inhibit the process by acting directly on the vascular wall. Alternatively, fetuin-A or &#x003b1;2-Heremans-Schmid glycoprotein, a circulating inhibitory factor, may stop the formation of hydroxyapatite crystals.[<xref rid="ref78" ref-type="bibr">78</xref>] Finally, adiponectin, an adipocyte derivative hormone, modulates osteoblastic differentiation through its receptors pathway 1/p38.[<xref rid="ref79" ref-type="bibr">79</xref>]</p></sec></sec><sec id="sec1-4"><title>V<sc>ascular</sc> C<sc>alcification</sc> A<sc>ssessment</sc></title><p>There are a number of noninvasive imaging tools that clinicians use to identify and assess vascular calcification. Nonetheless, all of them provide important information that could improve prediction of cardiovascular risk beyond the traditional risk factors, especially in patients with CKD, in which vascular calcification is an important component of the disease.[<xref rid="ref80" ref-type="bibr">80</xref>]</p><p>Through a plain radiography, it is possible to recognize patterns in the artery wall, which might differentiate <italic>tunica intima</italic> from <italic>tunica media</italic> calcification. Patchy and irregular radiopaque lesions on the artery course usually characterize intimal calcification. On the other hand, <italic>tunica media</italic> calcification typically presents as linear tram-track radiopaque lesion along the artery border (angiogram-like).[<xref rid="ref81" ref-type="bibr">81</xref><xref rid="ref82" ref-type="bibr">82</xref><xref rid="ref83" ref-type="bibr">83</xref>] In addition, carotid artery calcifications can be spotted on the panoramic radiograph below the mandibular angle and adjacent to the cervical vertebrae at the level of the intervertebral junction of C3 and C4.[<xref rid="ref84" ref-type="bibr">84</xref>]</p><p>Ultrasonography is a rapid, available, and inexpensive method to investigate the vascular system, due to its ability to both detect calcifications and measure the vascular thickness, blood flow, and its characteristics. Literature supports, as a prognostic tool, the measurement of the carotid intima-media thickness in the prediction of cardiovascular events.[<xref rid="ref85" ref-type="bibr">85</xref>] There are also reports in which renal and carotid artery calcification was easily detected with ultrasound.[<xref rid="ref84" ref-type="bibr">84</xref><xref rid="ref85" ref-type="bibr">85</xref><xref rid="ref86" ref-type="bibr">86</xref>]</p><p>The coronary artery calcium detection by CT scan is probably one of the most frequent and reliable methods to measure vascular calcification. Coronary artery calcium score is determined through the method of Agatston <italic>et al</italic>.,[<xref rid="ref87" ref-type="bibr">87</xref><xref rid="ref88" ref-type="bibr">88</xref>] an important predictor for the incidence of coronary artery disease correlated with the histological findings.[<xref rid="ref89" ref-type="bibr">89</xref><xref rid="ref90" ref-type="bibr">90</xref>] It is even considered that the degree of coronary artery calcium can be an isolated risk factor for acute coronary syndrome. Determining the coronary artery calcium score may detect coronary artery disease in asymptomatic patients and this allows therapeutic decision-making in the group of patients with subclinical coronary artery disease.[<xref rid="ref91" ref-type="bibr">91</xref><xref rid="ref92" ref-type="bibr">92</xref>] With the intent to clarify the coronary artery calcium score, a scale has been proposed [<xref ref-type="table" rid="T2">Table 2</xref>].[<xref rid="ref93" ref-type="bibr">93</xref>] An example of the usefulness of this coronary artery calcium score was reported in a study, in which asymptomatic patients for coronary artery disease with the diagnosis of diabetes mellitus were analyzed. During follow-up, the incidence of myocardial infarction was 0% in the group with a coronary artery calcium score from 0 to 10, 18.4% in patients with a score from 11 to 100, 22.9% in patients with 101&#x02013;400, 48.3% in the group with a score from 401 to 1000, and 71.4% in patients with over 1000 (<italic>P</italic> &#x0003c; 0.0001).[<xref rid="ref94" ref-type="bibr">94</xref>]</p><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Coronary artery calcium score classification according to the severity of the atherosclerotic involvement</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Coronary artery calcium score</th><th align="left" rowspan="1" colspan="1">Plaque burden</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">No evidence of coronary artery disease</td></tr><tr><td align="left" rowspan="1" colspan="1">0&#x02013;10</td><td align="left" rowspan="1" colspan="1">Minimal</td></tr><tr><td align="left" rowspan="1" colspan="1">11&#x02013;100</td><td align="left" rowspan="1" colspan="1">Mild</td></tr><tr><td align="left" rowspan="1" colspan="1">101&#x02013;400</td><td align="left" rowspan="1" colspan="1">Moderate</td></tr><tr><td align="left" rowspan="1" colspan="1">401&#x02013;1000</td><td align="left" rowspan="1" colspan="1">Severe</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x0003e;1000</td><td align="left" rowspan="1" colspan="1">Very severe</td></tr></tbody></table></table-wrap></sec><sec id="sec1-5"><title>C<sc>urrent and</sc> E<sc>merging</sc> T<sc>herapies for</sc> V<sc>ascular</sc> C<sc>alcification</sc></title><p>The best treatment for vascular calcification is the management of the risk factors that predispose to cardiovascular disease and the disorder of bone and mineral metabolism. Because hydroxyapatite is insoluble and stable under physiological conditions, the treatment for vascular calcification focuses on preventing its progression.[<xref rid="ref95" ref-type="bibr">95</xref>] Furthermore, several medications have been used for the treatment of vascular calcification in humans and animal models, which take a particular relevance in CKD patients.[<xref rid="ref96" ref-type="bibr">96</xref>]</p><p>Many therapies used in cardiovascular disease, osteoporosis, and CKD could be promising for treating vascular calcification. Some examples are as follows: (1) the endothelin receptor antagonists, which act by reducing blood pressure, (2) statins, which inhibit cholesterol production, (3) bisphosphonates, which inhibit osteoclast proliferation and survival, (4) denosumab and osteoprotegerin, which binds RANKL thus inhibiting binding to RANK, (5) teriparatide, which stimulates bone formation, (6) phosphate binder, which binds to dietary phosphate thus preventing its absorption, (7) Vitamin D receptor agonists, which treat secondary hyperparathyroidism and Vitamin D deficiency associated with CKD, (8) calcimimetics, which bind to calcium-sensing receptors treating secondary hyperparathyroidism, (9) Vitamin K, which is a cofactor in various metabolic pathways and frequently deficient in CKD patients, and (10) sodium thiosulfate, which acts as a vasodilator, antioxidant, and a calcium chelator thus preventing calcification.[<xref rid="ref96" ref-type="bibr">96</xref>]</p></sec><sec sec-type="conclusions" id="sec1-6"><title>C<sc>onclusions</sc></title><p>From the histological point of view, vascular calcification represents a complicated, multifactor disease that can be classified as <italic>tunica intima</italic> calcium deposition (atherosclerotic calcification) or <italic>tunica media</italic> calcification (M&#x000f6;nckenberg's sclerosis). The presence of this pathology increases the risks of adverse cardiovascular events and represents a serious public health problem. The pathophysiology of vascular calcification cannot be explained by a single specific factor; rather it is the result of the association of several genetic variants, molecular pathways interactions, and environmental factors that promote vascular calcification by either increasing osteogenesis or inhibiting its regulatory pathways. Although several molecular aspects of this disease have been elucidated, there is still a need for a better understanding of the factors that predispose to this disease.</p><sec id="sec2-3"><title>Financial support and sponsorship</title><p>This work was supported by a grant from the Consejo Nacional de Ciencia y Tecnolog&#x000ed;a (CONACYT) with the project number 261741.</p></sec><sec id="sec2-4" sec-type="COI-statement"><title>Conflicts of interest</title><p>There are no conflicts of interest.</p></sec></sec></body><back><fn-group><fn fn-type="edited-by"><p><bold>Edited by:</bold> Qiang Shi</p></fn></fn-group><ref-list><title>R<sc>eferences</sc></title><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>HC</given-names></name></person-group><article-title>Matrix vesicles and calcification</article-title><source>Curr Rheumatol Rep</source><year>2003</year><volume>5</volume><fpage>222</fpage><lpage>6</lpage><comment>doi: 10.1007/s11926-003-0071-z</comment><pub-id pub-id-type="pmid">12744815</pub-id></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reynolds</surname><given-names>JL</given-names></name><name><surname>Joannides</surname><given-names>AJ</given-names></name><name><surname>Skepper</surname><given-names>JN</given-names></name><name><surname>McNair</surname><given-names>R</given-names></name><name><surname>Schurgers</surname><given-names>LJ</given-names></name><name><surname>Proudfoot</surname><given-names>D</given-names></name><etal/></person-group><article-title>Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: A potential mechanism for accelerated vascular calcification in ESRD</article-title><source>J Am Soc Nephrol</source><year>2004</year><volume>15</volume><fpage>2857</fpage><lpage>67</lpage><comment>doi: 10.1097/01.ASN.0000141960.01035.28</comment><pub-id pub-id-type="pmid">15504939</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hofmann Bowman</surname><given-names>MA</given-names></name><name><surname>McNally</surname><given-names>EM</given-names></name></person-group><article-title>Genetic pathways of vascular calcification</article-title><source>Trends Cardiovasc Med</source><year>2012</year><volume>22</volume><fpage>93</fpage><lpage>8</lpage><comment>doi: 10.1016/j.tcm.2012.07.002</comment><pub-id pub-id-type="pmid">23040839</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garc&#x000ed;a-S&#x000e1;nchez</surname><given-names>C</given-names></name><name><surname>Posadas-Romero</surname><given-names>C</given-names></name><name><surname>Posadas-S&#x000e1;nchez</surname><given-names>R</given-names></name><name><surname>Carre&#x000f3;n-Torres</surname><given-names>E</given-names></name><name><surname>Rodr&#x000ed;guez-P&#x000e9;rez</surname><given-names>JM</given-names></name><name><surname>Ju&#x000e1;rez-Rojas</surname><given-names>JG</given-names></name><etal/></person-group><article-title>Low concentrations of phospholipids and plasma HDL cholesterol subclasses in asymptomatic subjects with high coronary calcium scores</article-title><source>Atherosclerosis</source><year>2015</year><volume>238</volume><fpage>250</fpage><lpage>5</lpage><comment>doi: 10.1016/j.atherosclerosis.2014.12.004</comment><pub-id pub-id-type="pmid">25528434</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>RC</given-names></name><name><surname>Leopold</surname><given-names>JA</given-names></name><name><surname>Loscalzo</surname><given-names>J</given-names></name></person-group><article-title>Vascular calcification: Pathobiological mechanisms and clinical implications</article-title><source>Circ Res</source><year>2006</year><volume>99</volume><fpage>1044</fpage><lpage>59</lpage><comment>doi: 10.1161/01.RES.0000249379.55535.21</comment><pub-id pub-id-type="pmid">17095733</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allam</surname><given-names>AH</given-names></name><name><surname>Thompson</surname><given-names>RC</given-names></name><name><surname>Wann</surname><given-names>LS</given-names></name><name><surname>Miyamoto</surname><given-names>MI</given-names></name><name><surname>Nur El-Din</surname><given-names>Ael-H</given-names></name><name><surname>El-Maksoud</surname><given-names>GA</given-names></name><etal/></person-group><article-title>Atherosclerosis in ancient Egyptian mummies: The Horus study</article-title><source>JACC Cardiovasc Imaging</source><year>2011</year><volume>4</volume><fpage>315</fpage><lpage>27</lpage><comment>doi: 10.1016/j.jcmg.2011.02.002</comment><pub-id pub-id-type="pmid">21466986</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rutsch</surname><given-names>F</given-names></name><name><surname>Nitschke</surname><given-names>Y</given-names></name><name><surname>Terkeltaub</surname><given-names>R</given-names></name></person-group><article-title>Genetics in arterial calcification pieces of a puzzle and cogs in a wheel</article-title><source>Circ Res</source><year>2012</year><volume>109</volume><fpage>578</fpage><lpage>92</lpage><comment>doi: 10.1161/CIRCRESAHA.111.247965</comment></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wayhs</surname><given-names>R</given-names></name><name><surname>Zelinger</surname><given-names>A</given-names></name><name><surname>Raggi</surname><given-names>P</given-names></name></person-group><article-title>High coronary artery calcium scores pose an extremely elevated risk for hard events</article-title><source>J Am Coll Cardiol</source><year>2002</year><volume>39</volume><fpage>225</fpage><lpage>30</lpage><comment>doi: 10.1016/S0735-1097(01)01737-5</comment><pub-id pub-id-type="pmid">11788211</pub-id></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kronmal</surname><given-names>RA</given-names></name><name><surname>McClelland</surname><given-names>RL</given-names></name><name><surname>Detrano</surname><given-names>R</given-names></name><name><surname>Shea</surname><given-names>S</given-names></name><name><surname>Lima</surname><given-names>JA</given-names></name><name><surname>Cushman</surname><given-names>M</given-names></name><etal/></person-group><article-title>Risk factors for the progression of coronary artery calcification in asymptomatic subjects: Results from the Multi-Ethnic Study of Atherosclerosis (MESA)</article-title><source>Circulation</source><year>2007</year><volume>115</volume><fpage>2722</fpage><lpage>30</lpage><comment>doi: 10.1161/CIRCULATIONAHA.106.674143</comment><pub-id pub-id-type="pmid">17502571</pub-id></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Assimes</surname><given-names>TL</given-names></name><name><surname>Knowles</surname><given-names>JW</given-names></name><name><surname>Basu</surname><given-names>A</given-names></name><name><surname>Iribarren</surname><given-names>C</given-names></name><name><surname>Southwick</surname><given-names>A</given-names></name><name><surname>Tang</surname><given-names>H</given-names></name><etal/></person-group><article-title>Susceptibility locus for clinical and subclinical coronary artery disease at chromosome 9p21 in the multi-ethnic ADVANCE study</article-title><source>Hum Mol Genet</source><year>2008</year><volume>17</volume><fpage>2320</fpage><lpage>8</lpage><comment>doi: 10.1093/hmg/ddn132</comment><pub-id pub-id-type="pmid">18443000</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Donnell</surname><given-names>CJ</given-names></name><name><surname>Kavousi</surname><given-names>M</given-names></name><name><surname>Smith</surname><given-names>AV</given-names></name><name><surname>Kardia</surname><given-names>SL</given-names></name><name><surname>Feitosa</surname><given-names>MF</given-names></name><name><surname>Hwang</surname><given-names>SJ</given-names></name><etal/></person-group><article-title>Genome-wide association study for coronary artery calcification with follow-up in myocardial infarction</article-title><source>Circulation</source><year>2011</year><volume>124</volume><fpage>2855</fpage><lpage>64</lpage><comment>doi: 10.1161/CIRCULATIONAHA.110.974899</comment><pub-id pub-id-type="pmid">22144573</pub-id></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>P&#x000e9;rez-Hern&#x000e1;ndez</surname><given-names>N</given-names></name><name><surname>Vargas-Alarc&#x000f3;n</surname><given-names>G</given-names></name><name><surname>Posadas-S&#x000e1;nchez</surname><given-names>R</given-names></name><name><surname>Mart&#x000ed;nez-Rodr&#x000ed;guez</surname><given-names>N</given-names></name><name><surname>Tovilla-Z&#x000e1;rate</surname><given-names>CA</given-names></name><name><surname>Rodr&#x000ed;guez-Cort&#x000e9;s</surname><given-names>AA</given-names></name><etal/></person-group><article-title>PHACTR1 gene polymorphism is associated with increased risk of developing premature coronary artery disease in Mexican population</article-title><source>Int J Environ Res Public Health</source><year>2016</year><volume>13</volume><comment>pii: E803. doi: 10.3390/ijerph13080803</comment></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lange</surname><given-names>LA</given-names></name><name><surname>Lange</surname><given-names>EM</given-names></name><name><surname>Bielak</surname><given-names>LF</given-names></name><name><surname>Langefeld</surname><given-names>CD</given-names></name><name><surname>Kardia</surname><given-names>SL</given-names></name><name><surname>Royston</surname><given-names>P</given-names></name><etal/></person-group><article-title>Autosomal genome-wide scan for coronary artery calcification loci in sibships at high risk for hypertension</article-title><source>Arterioscler Thromb Vasc Biol</source><year>2002</year><volume>22</volume><fpage>418</fpage><lpage>23</lpage><comment>doi: 10.1161/hq0302.105721</comment><pub-id pub-id-type="pmid">11884284</pub-id></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Demer</surname><given-names>LL</given-names></name></person-group><article-title>A skeleton in the atherosclerosis closet</article-title><source>Circulation</source><year>1995</year><volume>92</volume><fpage>2029</fpage><lpage>32</lpage><comment>doi: 10.1161/01.CIR.92.8.2029</comment><pub-id pub-id-type="pmid">7554176</pub-id></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watson</surname><given-names>KE</given-names></name><name><surname>Bostr&#x000f6;m</surname><given-names>K</given-names></name><name><surname>Ravindranath</surname><given-names>R</given-names></name><name><surname>Lam</surname><given-names>T</given-names></name><name><surname>Norton</surname><given-names>B</given-names></name><name><surname>Demer</surname><given-names>LL</given-names></name></person-group><article-title>TGF-beta 1 and 25-hydroxycholesterol stimulate osteoblast-like vascular cells to calcify</article-title><source>J Clin Invest</source><year>1994</year><volume>93</volume><fpage>2106</fpage><lpage>13</lpage><comment>doi: 10.1172/JCI117205</comment><pub-id pub-id-type="pmid">8182141</pub-id></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doherty</surname><given-names>MJ</given-names></name><name><surname>Canfield</surname><given-names>AE</given-names></name></person-group><article-title>Gene expression during vascular pericyte differentiation</article-title><source>Crit Rev Eukaryot Gene Expr</source><year>1999</year><volume>9</volume><fpage>1</fpage><lpage>17</lpage><pub-id pub-id-type="pmid">10200908</pub-id></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doherty</surname><given-names>MJ</given-names></name><name><surname>Ashton</surname><given-names>BA</given-names></name><name><surname>Walsh</surname><given-names>S</given-names></name><name><surname>Beresford</surname><given-names>JN</given-names></name><name><surname>Grant</surname><given-names>ME</given-names></name><name><surname>Canfield</surname><given-names>AE</given-names></name></person-group><article-title>Vascular pericytes express osteogenic potential <italic>in vitro</italic> and <italic>in vivo</italic></article-title><source>J Bone Miner Res</source><year>1998</year><volume>13</volume><fpage>828</fpage><lpage>38</lpage><comment>doi: 10.1359/jbmr.1998.13.5.828</comment><pub-id pub-id-type="pmid">9610747</pub-id></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hern&#x000e1;ndez-Pacheco</surname><given-names>G</given-names></name><name><surname>Murgu&#x000ed;a</surname><given-names>LE</given-names></name><name><surname>Rodr&#x000ed;guez-P&#x000e9;rez</surname><given-names>JM</given-names></name><name><surname>Fragoso</surname><given-names>JM</given-names></name><name><surname>P&#x000e9;rez-Vielma</surname><given-names>N</given-names></name><name><surname>Mart&#x000ed;nez-Rodr&#x000ed;guez</surname><given-names>N</given-names></name><etal/></person-group><article-title>Matrix gamma-carboxyglutamic acid protein (MGP) G-7A and T-138C gene polymorphisms in Indian (Mayo and Teenek) and Mestizo populations from Mexico</article-title><source>Hum Biol</source><year>2005</year><volume>77</volume><fpage>385</fpage><lpage>91</lpage><comment>doi: 10.1353/hub.2005.0048</comment><pub-id pub-id-type="pmid">16392639</pub-id></element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerhardt</surname><given-names>H</given-names></name><name><surname>Betsholtz</surname><given-names>C</given-names></name></person-group><article-title>Endothelial-pericyte interactions in angiogenesis</article-title><source>Cell Tissue Res</source><year>2003</year><volume>314</volume><fpage>15</fpage><lpage>23</lpage><comment>doi: 10.1007/s00441-003-0745-x</comment><pub-id pub-id-type="pmid">12883993</pub-id></element-citation></ref><ref id="ref20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamat</surname><given-names>BR</given-names></name><name><surname>Galli</surname><given-names>SJ</given-names></name><name><surname>Barger</surname><given-names>AC</given-names></name><name><surname>Lainey</surname><given-names>LL</given-names></name><name><surname>Silverman</surname><given-names>KJ</given-names></name></person-group><article-title>Neovascularization and coronary atherosclerotic plaque: Cinematographic localization and quantitative histologic analysis</article-title><source>Hum Pathol</source><year>1987</year><volume>18</volume><fpage>1036</fpage><lpage>42</lpage><comment>doi: 10.1016/S0046-8177(87)80220-4</comment><pub-id pub-id-type="pmid">2443438</pub-id></element-citation></ref><ref id="ref21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dorai</surname><given-names>H</given-names></name><name><surname>Vukicevic</surname><given-names>S</given-names></name><name><surname>Sampath</surname><given-names>TK</given-names></name></person-group><article-title>Bone morphogenetic protein-7 (osteogenic protein-1) inhibits smooth muscle cell proliferation and stimulates the expression of markers that are characteristic of SMC phenotype <italic>in vitro</italic></article-title><source>J Cell Physiol</source><year>2000</year><volume>184</volume><fpage>37</fpage><lpage>45</lpage><comment>doi: 10.1002/(SICI)1097-4652(200007)184:1&#x0003c;37:AID-JCP4&#x0003e;3.0.CO;2-M</comment><pub-id pub-id-type="pmid">10825232</pub-id></element-citation></ref><ref id="ref22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hruska</surname><given-names>KA</given-names></name><name><surname>Mathew</surname><given-names>S</given-names></name><name><surname>Saab</surname><given-names>G</given-names></name></person-group><article-title>Bone morphogenetic proteins in vascular calcification</article-title><source>Circ Res</source><year>2005</year><volume>97</volume><fpage>105</fpage><lpage>14</lpage><comment>doi: 10.1161/01.RES.00000175571.53833.6c</comment><pub-id pub-id-type="pmid">16037577</pub-id></element-citation></ref><ref id="ref23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Massagu&#x000e9;</surname><given-names>J</given-names></name><name><surname>Wotton</surname><given-names>D</given-names></name></person-group><article-title>Transcriptional control by the TGF-beta/Smad signaling system</article-title><source>EMBO J</source><year>2000</year><volume>19</volume><fpage>1745</fpage><lpage>54</lpage><comment>doi: 10.1093/emboj/19.8.1745</comment><pub-id pub-id-type="pmid">10775259</pub-id></element-citation></ref><ref id="ref24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>AL</given-names></name><name><surname>Fang</surname><given-names>C</given-names></name><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Leslie</surname><given-names>MP</given-names></name><name><surname>Chang</surname><given-names>E</given-names></name><name><surname>Di Cesare</surname><given-names>PE</given-names></name></person-group><article-title>Expression of bone morphogenetic proteins, receptors, and tissue inhibitors in human fetal, adult, and osteoarthritic articular cartilage</article-title><source>J Orthop Res</source><year>2004</year><volume>22</volume><fpage>1188</fpage><lpage>92</lpage><comment>doi: 10.1016/j.orthres.2004.02.013</comment><pub-id pub-id-type="pmid">15475196</pub-id></element-citation></ref><ref id="ref25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>D</given-names></name><name><surname>Zhao</surname><given-names>M</given-names></name><name><surname>Mundy</surname><given-names>GR</given-names></name></person-group><article-title>Bone morphogenetic proteins</article-title><source>Growth Factors</source><year>2004</year><volume>22</volume><fpage>233</fpage><lpage>41</lpage><comment>doi: 10.1080/08977190412331279890</comment><pub-id pub-id-type="pmid">15621726</pub-id></element-citation></ref><ref id="ref26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>ten Dijke</surname><given-names>P</given-names></name><name><surname>Fu</surname><given-names>J</given-names></name><name><surname>Schaap</surname><given-names>P</given-names></name><name><surname>Roelen</surname><given-names>BA</given-names></name></person-group><article-title>Signal transduction of bone morphogenetic proteins in osteoblast differentiation</article-title><source>J Bone Joint Surg Am</source><year>2003</year><volume>85-A</volume><issue>Suppl 3</issue><fpage>34</fpage><lpage>8</lpage></element-citation></ref><ref id="ref27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freedman</surname><given-names>BI</given-names></name><name><surname>Bowden</surname><given-names>DW</given-names></name><name><surname>Ziegler</surname><given-names>JT</given-names></name><name><surname>Langefeld</surname><given-names>CD</given-names></name><name><surname>Lehtinen</surname><given-names>AB</given-names></name><name><surname>Rudock</surname><given-names>ME</given-names></name><etal/></person-group><article-title>Bone morphogenetic protein 7 (BMP7) gene polymorphisms are associated with inverse relationships between vascular calcification and BMD: The Diabetes Heart Study</article-title><source>J Bone Miner Res</source><year>2009</year><volume>24</volume><fpage>1719</fpage><lpage>27</lpage><comment>doi: 10.1359/jbmr.090501</comment><pub-id pub-id-type="pmid">19453255</pub-id></element-citation></ref><ref id="ref28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ducy</surname><given-names>P</given-names></name><name><surname>Zhang</surname><given-names>R</given-names></name><name><surname>Geoffroy</surname><given-names>V</given-names></name><name><surname>Ridall</surname><given-names>AL</given-names></name><name><surname>Karsenty</surname><given-names>G</given-names></name></person-group><article-title>Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation</article-title><source>Cell</source><year>1997</year><volume>89</volume><fpage>747</fpage><lpage>54</lpage><comment>doi: 10.1016/S0092-8674(00)80257-3</comment><pub-id pub-id-type="pmid">9182762</pub-id></element-citation></ref><ref id="ref29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Komori</surname><given-names>T</given-names></name><name><surname>Yagi</surname><given-names>H</given-names></name><name><surname>Nomura</surname><given-names>S</given-names></name><name><surname>Yamaguchi</surname><given-names>A</given-names></name><name><surname>Sasaki</surname><given-names>K</given-names></name><name><surname>Deguchi</surname><given-names>K</given-names></name><etal/></person-group><article-title>Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts</article-title><source>Cell</source><year>1997</year><volume>89</volume><fpage>755</fpage><lpage>64</lpage><comment>doi: 10.1016/S0092-8674(00)80258-5</comment><pub-id pub-id-type="pmid">9182763</pub-id></element-citation></ref><ref id="ref30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cola</surname><given-names>C</given-names></name><name><surname>Almeida</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>D</given-names></name><name><surname>Romeo</surname><given-names>F</given-names></name><name><surname>Mehta</surname><given-names>JL</given-names></name></person-group><article-title>Regulatory role of endothelium in the expression of genes affecting arterial calcification</article-title><source>Biochem Biophys Res Commun</source><year>2004</year><volume>320</volume><fpage>424</fpage><lpage>7</lpage><comment>doi: 10.1016/j.bbrc.2004.05.181</comment><pub-id pub-id-type="pmid">15219845</pub-id></element-citation></ref><ref id="ref31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steitz</surname><given-names>SA</given-names></name><name><surname>Speer</surname><given-names>MY</given-names></name><name><surname>Curinga</surname><given-names>G</given-names></name><name><surname>Yang</surname><given-names>HY</given-names></name><name><surname>Haynes</surname><given-names>P</given-names></name><name><surname>Aebersold</surname><given-names>R</given-names></name><etal/></person-group><article-title>Smooth muscle cell phenotypic transition associated with calcification: Upregulation of Cbfa1 and downregulation of smooth muscle lineage markers</article-title><source>Circ Res</source><year>2001</year><volume>89</volume><fpage>1147</fpage><lpage>54</lpage><comment>doi: 10.1161/hh2401.101070</comment><pub-id pub-id-type="pmid">11739279</pub-id></element-citation></ref><ref id="ref32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jono</surname><given-names>S</given-names></name><name><surname>McKee</surname><given-names>MD</given-names></name><name><surname>Murry</surname><given-names>CE</given-names></name><name><surname>Shioi</surname><given-names>A</given-names></name><name><surname>Nishizawa</surname><given-names>Y</given-names></name><name><surname>Mori</surname><given-names>K</given-names></name><etal/></person-group><article-title>Phosphate regulation of vascular smooth muscle cell calcification</article-title><source>Circ Res</source><year>2000</year><volume>87</volume><fpage>e10</fpage><lpage>7</lpage><comment>doi: 10.1161/01.RES.87.7.e10</comment><pub-id pub-id-type="pmid">11009570</pub-id></element-citation></ref><ref id="ref33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>NX</given-names></name><name><surname>O&#x02019;Neill</surname><given-names>KD</given-names></name><name><surname>Duan</surname><given-names>D</given-names></name><name><surname>Moe</surname><given-names>SM</given-names></name></person-group><article-title>Phosphorus and uremic serum up-regulate osteopontin expression in vascular smooth muscle cells</article-title><source>Kidney Int</source><year>2002</year><volume>62</volume><fpage>1724</fpage><lpage>31</lpage><comment>doi: 10.1046/j.1523-1755.2002.00625.x</comment><pub-id pub-id-type="pmid">12371973</pub-id></element-citation></ref><ref id="ref34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moe</surname><given-names>SM</given-names></name><name><surname>Chen</surname><given-names>NX</given-names></name></person-group><article-title>Mechanisms of vascular calcification in chronic kidney disease</article-title><source>J Am Soc Nephrol</source><year>2008</year><volume>19</volume><fpage>213</fpage><lpage>6</lpage><comment>doi: 10.1681/ASN.2007080854</comment><pub-id pub-id-type="pmid">18094365</pub-id></element-citation></ref><ref id="ref35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giachelli</surname><given-names>CM</given-names></name></person-group><article-title>Vascular calcification: <italic>In vitro</italic> evidence for the role of inorganic phosphate</article-title><source>J Am Soc Nephrol</source><year>2003</year><volume>14</volume><issue>9 Suppl 4</issue><fpage>S300</fpage><lpage>4</lpage><comment>doi: 10.1097/01.ASN.0000081663.52165.66</comment><pub-id pub-id-type="pmid">12939385</pub-id></element-citation></ref><ref id="ref36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Yang</surname><given-names>HY</given-names></name><name><surname>Giachelli</surname><given-names>CM</given-names></name></person-group><article-title>Role of the sodium-dependent phosphate cotransporter, Pit-1, in vascular smooth muscle cell calcification</article-title><source>Circ Res</source><year>2006</year><volume>98</volume><fpage>905</fpage><lpage>12</lpage><comment>doi: 10.1161/01.RES.0000216409.20863.e7</comment><pub-id pub-id-type="pmid">16527991</pub-id></element-citation></ref><ref id="ref37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Franceschi</surname><given-names>RT</given-names></name><name><surname>Xiao</surname><given-names>G</given-names></name></person-group><article-title>Regulation of the osteoblast-specific transcription factor, Runx2: Responsiveness to multiple signal transduction pathways</article-title><source>J Cell Biochem</source><year>2003</year><volume>88</volume><fpage>446</fpage><lpage>54</lpage><comment>doi: 10.1002/jcb.10369</comment><pub-id pub-id-type="pmid">12532321</pub-id></element-citation></ref><ref id="ref38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swarthout</surname><given-names>JT</given-names></name><name><surname>D&#x02019;Alonzo</surname><given-names>RC</given-names></name><name><surname>Selvamurugan</surname><given-names>N</given-names></name><name><surname>Partridge</surname><given-names>NC</given-names></name></person-group><article-title>Parathyroid hormone-dependent signaling pathways regulating genes in bone cells</article-title><source>Gene</source><year>2002</year><volume>282</volume><fpage>1</fpage><lpage>17</lpage><comment>doi: 10.1016/S0378-1119(01)00798-3</comment><pub-id pub-id-type="pmid">11814673</pub-id></element-citation></ref><ref id="ref39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Higgins</surname><given-names>CL</given-names></name><name><surname>Isbilir</surname><given-names>S</given-names></name><name><surname>Basto</surname><given-names>P</given-names></name><name><surname>Chen</surname><given-names>IY</given-names></name><name><surname>Vaduganathan</surname><given-names>M</given-names></name><name><surname>Vaduganathan</surname><given-names>P</given-names></name><etal/></person-group><article-title>Distribution of alkaline phosphatase, osteopontin, RANK ligand and osteoprotegerin in calcified human carotid atheroma</article-title><source>Protein J</source><year>2015</year><volume>34</volume><fpage>315</fpage><lpage>28</lpage><comment>doi: 10.1007/s10930-015-9620-3</comment><pub-id pub-id-type="pmid">26307009</pub-id></element-citation></ref><ref id="ref40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>HJ</given-names></name><name><surname>Li</surname><given-names>TF</given-names></name><name><surname>Guo</surname><given-names>JL</given-names></name><name><surname>Lan</surname><given-names>YL</given-names></name><name><surname>Kong</surname><given-names>YQ</given-names></name><name><surname>Meng</surname><given-names>X</given-names></name><etal/></person-group><article-title>Effects of high glucose on expression of OPG and RANKL in rat aortic vascular smooth muscle cells</article-title><source>Asian Pac J Trop Med</source><year>2015</year><volume>8</volume><fpage>209</fpage><lpage>13</lpage><comment>doi: 10.1016/S1995-7645(14)60317-5</comment><pub-id pub-id-type="pmid">25902163</pub-id></element-citation></ref><ref id="ref41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirton</surname><given-names>JP</given-names></name><name><surname>Wilkinson</surname><given-names>FL</given-names></name><name><surname>Canfield</surname><given-names>AE</given-names></name><name><surname>Alexander</surname><given-names>MY</given-names></name></person-group><article-title>Dexamethasone downregulates calcification-inhibitor molecules and accelerates osteogenic differentiation of vascular pericytes: Implications for vascular calcification</article-title><source>Circ Res</source><year>2006</year><volume>98</volume><fpage>1264</fpage><lpage>72</lpage><comment>doi: 10.1161/01.RES.0000223056.68892.8b</comment><pub-id pub-id-type="pmid">16627786</pub-id></element-citation></ref><ref id="ref42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>P&#x000e9;rez-Hern&#x000e1;ndez</surname><given-names>N</given-names></name><name><surname>Aptilon-Duque</surname><given-names>G</given-names></name><name><surname>Nostroza-Hern&#x000e1;ndez</surname><given-names>MC</given-names></name><name><surname>Vargas-Alarc&#x000f3;n</surname><given-names>G</given-names></name><name><surname>Rodr&#x000ed;guez-P&#x000e9;rez</surname><given-names>JM</given-names></name><name><surname>Blachman-Braun</surname><given-names>R</given-names></name><etal/></person-group><article-title>Vitamin D and its effects on cardiovascular diseases: A comprehensive review</article-title><source>Korean J Intern Med</source><year>2016</year><volume>31</volume><fpage>1018</fpage><lpage>1029</lpage><comment>doi: 10.3904/kjim.2015.224</comment><pub-id pub-id-type="pmid">27117316</pub-id></element-citation></ref><ref id="ref43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jono</surname><given-names>S</given-names></name><name><surname>Nishizawa</surname><given-names>Y</given-names></name><name><surname>Shioi</surname><given-names>A</given-names></name><name><surname>Morii</surname><given-names>H</given-names></name></person-group><article-title>1,25-Dihydroxyvitamin D3 increases <italic>in vitro</italic> vascular calcification by modulating secretion of endogenous parathyroid hormone-related peptide</article-title><source>Circulation</source><year>1998</year><volume>98</volume><fpage>1302</fpage><lpage>6</lpage><comment>doi: 10.1161/01.CIR.98.13.1302</comment><pub-id pub-id-type="pmid">9751679</pub-id></element-citation></ref><ref id="ref44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haussler</surname><given-names>MR</given-names></name><name><surname>Whitfield</surname><given-names>GK</given-names></name><name><surname>Haussler</surname><given-names>CA</given-names></name><name><surname>Hsieh</surname><given-names>JC</given-names></name><name><surname>Thompson</surname><given-names>PD</given-names></name><name><surname>Selznick</surname><given-names>SH</given-names></name><etal/></person-group><article-title>The nuclear Vitamin D receptor: Biological and molecular regulatory properties revealed</article-title><source>J Bone Miner Res</source><year>1998</year><volume>13</volume><fpage>325</fpage><lpage>49</lpage><comment>doi: 10.1359/jbmr.1998.13.3.325</comment><pub-id pub-id-type="pmid">9525333</pub-id></element-citation></ref><ref id="ref45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>St-Arnaud</surname><given-names>R</given-names></name><name><surname>Arabian</surname><given-names>A</given-names></name><name><surname>Travers</surname><given-names>R</given-names></name><name><surname>Barletta</surname><given-names>F</given-names></name><name><surname>Raval-Pandya</surname><given-names>M</given-names></name><name><surname>Chapin</surname><given-names>K</given-names></name><etal/></person-group><article-title>Deficient mineralization of intramembranous bone in Vitamin D-24-hydroxylase-ablated mice is due to elevated 1,25-dihydroxyvitamin D and not to the absence of 24,25-dihydroxyvitamin D</article-title><source>Endocrinology</source><year>2000</year><volume>141</volume><fpage>2658</fpage><lpage>66</lpage><comment>doi: 10.1210/endo.141.7.7579</comment><pub-id pub-id-type="pmid">10875271</pub-id></element-citation></ref><ref id="ref46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moss</surname><given-names>DW</given-names></name><name><surname>Eaton</surname><given-names>RH</given-names></name><name><surname>Smith</surname><given-names>JK</given-names></name><name><surname>Whitby</surname><given-names>LG</given-names></name></person-group><article-title>Association of inorganic-pyrophosphatase activity with human alkaline-phosphatase preparations</article-title><source>Biochem J</source><year>1967</year><volume>102</volume><fpage>53</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">6030299</pub-id></element-citation></ref><ref id="ref47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lomashvili</surname><given-names>KA</given-names></name><name><surname>Cobbs</surname><given-names>S</given-names></name><name><surname>Hennigar</surname><given-names>RA</given-names></name><name><surname>Hardcastle</surname><given-names>KI</given-names></name><name><surname>O&#x02019;Neill</surname><given-names>WC</given-names></name></person-group><article-title>Phosphate-induced vascular calcification: Role of pyrophosphate and osteopontin</article-title><source>J Am Soc Nephrol</source><year>2004</year><volume>15</volume><fpage>1392</fpage><lpage>401</lpage><comment>doi: 10.1097/01.ASN.0000128955.83129.9C</comment><pub-id pub-id-type="pmid">15153550</pub-id></element-citation></ref><ref id="ref48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ducy</surname><given-names>P</given-names></name><name><surname>Amling</surname><given-names>M</given-names></name><name><surname>Takeda</surname><given-names>S</given-names></name><name><surname>Priemel</surname><given-names>M</given-names></name><name><surname>Schilling</surname><given-names>AF</given-names></name><name><surname>Beil</surname><given-names>FT</given-names></name><etal/></person-group><article-title>Leptin inhibits bone formation through a hypothalamic relay: A central control of bone mass</article-title><source>Cell</source><year>2000</year><volume>100</volume><fpage>197</fpage><lpage>207</lpage><comment>doi: 10.1016/S0092-8674(00)81558-5</comment><pub-id pub-id-type="pmid">10660043</pub-id></element-citation></ref><ref id="ref49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takeda</surname><given-names>S</given-names></name><name><surname>Elefteriou</surname><given-names>F</given-names></name><name><surname>Levasseur</surname><given-names>R</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Zhao</surname><given-names>L</given-names></name><name><surname>Parker</surname><given-names>KL</given-names></name><etal/></person-group><article-title>Leptin regulates bone formation via the sympathetic nervous system</article-title><source>Cell</source><year>2002</year><volume>111</volume><fpage>305</fpage><lpage>17</lpage><comment>doi: 10.1016/S0092-8674(02)01049-8</comment><pub-id pub-id-type="pmid">12419242</pub-id></element-citation></ref><ref id="ref50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>T</given-names></name><name><surname>Gori</surname><given-names>F</given-names></name><name><surname>Khosla</surname><given-names>S</given-names></name><name><surname>Jensen</surname><given-names>MD</given-names></name><name><surname>Burguera</surname><given-names>B</given-names></name><name><surname>Riggs</surname><given-names>BL</given-names></name></person-group><article-title>Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes</article-title><source>Endocrinology</source><year>1999</year><volume>140</volume><fpage>1630</fpage><lpage>8</lpage><comment>doi: 10.1210/endo.140.4.6637</comment><pub-id pub-id-type="pmid">10098497</pub-id></element-citation></ref><ref id="ref51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parhami</surname><given-names>F</given-names></name><name><surname>Tintut</surname><given-names>Y</given-names></name><name><surname>Ballard</surname><given-names>A</given-names></name><name><surname>Fogelman</surname><given-names>AM</given-names></name><name><surname>Demer</surname><given-names>LL</given-names></name></person-group><article-title>Leptin enhances the calcification of vascular cells: Artery wall as a target of leptin</article-title><source>Circ Res</source><year>2001</year><volume>88</volume><fpage>954</fpage><lpage>60</lpage><comment>doi: 10.1161/hh0901.090975</comment><pub-id pub-id-type="pmid">11349006</pub-id></element-citation></ref><ref id="ref52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamagishi</surname><given-names>SI</given-names></name><name><surname>Edelstein</surname><given-names>D</given-names></name><name><surname>Du</surname><given-names>XL</given-names></name><name><surname>Kaneda</surname><given-names>Y</given-names></name><name><surname>Guzm&#x000e1;n</surname><given-names>M</given-names></name><name><surname>Brownlee</surname><given-names>M</given-names></name></person-group><article-title>Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A</article-title><source>J Biol Chem</source><year>2001</year><volume>276</volume><fpage>25096</fpage><lpage>100</lpage><comment>doi: 10.1074/jbc.M007383200</comment><pub-id pub-id-type="pmid">11342529</pub-id></element-citation></ref><ref id="ref53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sorescu</surname><given-names>GP</given-names></name><name><surname>Sykes</surname><given-names>M</given-names></name><name><surname>Weiss</surname><given-names>D</given-names></name><name><surname>Platt</surname><given-names>MO</given-names></name><name><surname>Saha</surname><given-names>A</given-names></name><name><surname>Hwang</surname><given-names>J</given-names></name><etal/></person-group><article-title>Bone morphogenic protein 4 produced in endothelial cells by oscillatory shear stress stimulates an inflammatory response</article-title><source>J Biol Chem</source><year>2003</year><volume>278</volume><fpage>31128</fpage><lpage>35</lpage><comment>doi: 10.1074/jbc.M300703200</comment><pub-id pub-id-type="pmid">12766166</pub-id></element-citation></ref><ref id="ref54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rutsch</surname><given-names>F</given-names></name><name><surname>Ruf</surname><given-names>N</given-names></name><name><surname>Vaingankar</surname><given-names>S</given-names></name><name><surname>Toliat</surname><given-names>MR</given-names></name><name><surname>Suk</surname><given-names>A</given-names></name><name><surname>H&#x000f6;hne</surname><given-names>W</given-names></name><etal/></person-group><article-title>Mutations in ENPP1 are associated with &#x02018;idiopathic&#x02019; infantile arterial calcification</article-title><source>Nat Genet</source><year>2003</year><volume>34</volume><fpage>379</fpage><lpage>81</lpage><comment>doi: 10.1038/ng1221</comment><pub-id pub-id-type="pmid">12881724</pub-id></element-citation></ref><ref id="ref55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruf</surname><given-names>N</given-names></name><name><surname>Uhlenberg</surname><given-names>B</given-names></name><name><surname>Terkeltaub</surname><given-names>R</given-names></name><name><surname>N&#x000fc;rnberg</surname><given-names>P</given-names></name><name><surname>Rutsch</surname><given-names>F</given-names></name></person-group><article-title>The mutational spectrum of ENPP1 as arising after the analysis of 23 unrelated patients with generalized arterial calcification of infancy (GACI)</article-title><source>Hum Mutat</source><year>2005</year><volume>25</volume><fpage>98</fpage><comment>doi: 10.1002/humu.9297</comment></element-citation></ref><ref id="ref56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nitschke</surname><given-names>Y</given-names></name><name><surname>Weissen-Plenz</surname><given-names>G</given-names></name><name><surname>Terkeltaub</surname><given-names>R</given-names></name><name><surname>Rutsch</surname><given-names>F</given-names></name></person-group><article-title>Npp1 promotes atherosclerosis in ApoE knockout mice</article-title><source>J Cell Mol Med</source><year>2011</year><volume>15</volume><fpage>2273</fpage><lpage>83</lpage><comment>doi: 10.1111/j.1582-4934.2011.01327.x</comment><pub-id pub-id-type="pmid">21477221</pub-id></element-citation></ref><ref id="ref57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>St. Hilaire</surname><given-names>C</given-names></name><name><surname>Ziegler</surname><given-names>SG</given-names></name><name><surname>Markello</surname><given-names>TC</given-names></name><name><surname>Brusco</surname><given-names>A</given-names></name><name><surname>Groden</surname><given-names>C</given-names></name><name><surname>Gill</surname><given-names>F</given-names></name><etal/></person-group><article-title>NT5E mutations and arterial calcifications</article-title><source>N Engl J Med</source><year>2011</year><volume>364</volume><fpage>432</fpage><lpage>42</lpage><comment>doi: 10.1056/NEJMc1102515#SA1</comment><pub-id pub-id-type="pmid">21288095</pub-id></element-citation></ref><ref id="ref58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klement</surname><given-names>JF</given-names></name><name><surname>Matsuzaki</surname><given-names>Y</given-names></name><name><surname>Jiang</surname><given-names>QJ</given-names></name><name><surname>Terlizzi</surname><given-names>J</given-names></name><name><surname>Choi</surname><given-names>HY</given-names></name><name><surname>Fujimoto</surname><given-names>N</given-names></name><etal/></person-group><article-title>Targeted ablation of the abcc6 gene results in ectopic mineralization of connective tissues</article-title><source>Mol Cell Biol</source><year>2005</year><volume>25</volume><fpage>8299</fpage><lpage>310</lpage><comment>doi: 10.1128/MCB.25.18.8299-8310.2005</comment><pub-id pub-id-type="pmid">16135817</pub-id></element-citation></ref><ref id="ref59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gorgels</surname><given-names>TG</given-names></name><name><surname>Hu</surname><given-names>X</given-names></name><name><surname>Scheffer</surname><given-names>GL</given-names></name><name><surname>van der Wal</surname><given-names>AC</given-names></name><name><surname>Toonstra</surname><given-names>J</given-names></name><name><surname>de Jong</surname><given-names>PT</given-names></name><etal/></person-group><article-title>Disruption of Abcc6 in the mouse: Novel insight in the pathogenesis of pseudoxanthoma elasticum</article-title><source>Hum Mol Genet</source><year>2005</year><volume>14</volume><fpage>1763</fpage><lpage>73</lpage><comment>doi: 10.1093/hmg/ddi183</comment><pub-id pub-id-type="pmid">15888484</pub-id></element-citation></ref><ref id="ref60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meng</surname><given-names>H</given-names></name><name><surname>Vera</surname><given-names>I</given-names></name><name><surname>Che</surname><given-names>N</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>SS</given-names></name><name><surname>Ingram-Drake</surname><given-names>L</given-names></name><etal/></person-group><article-title>Identification of Abcc6 as the major causal gene for dystrophic cardiac calcification in mice through integrative genomics</article-title><source>Proc Natl Acad Sci U S A</source><year>2007</year><volume>104</volume><fpage>4530</fpage><lpage>5</lpage><comment>doi: 10.1073/pnas.0607620104</comment><pub-id pub-id-type="pmid">17360558</pub-id></element-citation></ref><ref id="ref61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Markello</surname><given-names>TC</given-names></name><name><surname>Pak</surname><given-names>LK</given-names></name><name><surname>St. Hilaire</surname><given-names>C</given-names></name><name><surname>Dorward</surname><given-names>H</given-names></name><name><surname>Ziegler</surname><given-names>SG</given-names></name><name><surname>Chen</surname><given-names>MY</given-names></name><etal/></person-group><article-title>Vascular pathology of medial arterial calcifications in NT5E deficiency: Implications for the role of adenosine in pseudoxanthoma elasticum</article-title><source>Mol Genet Metab</source><year>2011</year><volume>103</volume><fpage>44</fpage><lpage>50</lpage><comment>doi: 10.1016/j.ymgme.2011.03.014</comment><pub-id pub-id-type="pmid">21371928</pub-id></element-citation></ref><ref id="ref62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Jiang</surname><given-names>Q</given-names></name><name><surname>Schurgers</surname><given-names>LJ</given-names></name><name><surname>Uitto</surname><given-names>J</given-names></name></person-group><article-title>Pseudoxanthoma elasticum: Reduced gamma-glutamyl carboxylation of matrix gla protein in a mouse model (Abcc6&#x02013;/&#x02013;)</article-title><source>Biochem Biophys Res Commun</source><year>2007</year><volume>364</volume><fpage>208</fpage><lpage>13</lpage><comment>doi: 10.1016/j.bbrc.2007.09.122</comment><pub-id pub-id-type="pmid">17942075</pub-id></element-citation></ref><ref id="ref63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cecil</surname><given-names>DL</given-names></name><name><surname>Terkeltaub</surname><given-names>RA</given-names></name></person-group><article-title>Arterial calcification is driven by RAGE in Enpp1&#x02013;/&#x02013; mice</article-title><source>J Vasc Res</source><year>2011</year><volume>48</volume><fpage>227</fpage><lpage>35</lpage><comment>doi: 10.1159/000318805</comment><pub-id pub-id-type="pmid">21099228</pub-id></element-citation></ref><ref id="ref64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hofmann</surname><given-names>MA</given-names></name><name><surname>Drury</surname><given-names>S</given-names></name><name><surname>Fu</surname><given-names>C</given-names></name><name><surname>Qu</surname><given-names>W</given-names></name><name><surname>Taguchi</surname><given-names>A</given-names></name><name><surname>Lu</surname><given-names>Y</given-names></name><etal/></person-group><article-title>RAGE mediates a novel proinflammatory axis: A central cell surface receptor for S100/calgranulin polypeptides</article-title><source>Cell</source><year>1999</year><volume>97</volume><fpage>889</fpage><lpage>901</lpage><comment>doi: 10.1016/S0092-8674(00)80801-6</comment><pub-id pub-id-type="pmid">10399917</pub-id></element-citation></ref><ref id="ref65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>SF</given-names></name><name><surname>Ramasamy</surname><given-names>R</given-names></name><name><surname>Schmidt</surname><given-names>AM</given-names></name></person-group><article-title>The RAGE axis: A fundamental mechanism signaling danger to the vulnerable vasculature</article-title><source>Circ Res</source><year>2010</year><volume>106</volume><fpage>842</fpage><lpage>53</lpage><comment>doi: 10.1161/CIRCRESAHA.109.212217</comment><pub-id pub-id-type="pmid">20299674</pub-id></element-citation></ref><ref id="ref66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harja</surname><given-names>E</given-names></name><name><surname>Bu</surname><given-names>DX</given-names></name><name><surname>Hudson</surname><given-names>BI</given-names></name><name><surname>Chang</surname><given-names>JS</given-names></name><name><surname>Shen</surname><given-names>X</given-names></name><name><surname>Hallam</surname><given-names>K</given-names></name><etal/></person-group><article-title>Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE&#x02013;/&#x02013; mice</article-title><source>J Clin Invest</source><year>2008</year><volume>118</volume><fpage>183</fpage><lpage>94</lpage><comment>doi: 10.1172/JCI32703</comment><pub-id pub-id-type="pmid">18079965</pub-id></element-citation></ref><ref id="ref67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Averill</surname><given-names>MM</given-names></name><name><surname>Kerkhoff</surname><given-names>C</given-names></name><name><surname>Bornfeldt</surname><given-names>KE</given-names></name></person-group><article-title>S100A8 and S100A9 in cardiovascular biology and disease</article-title><source>Arterioscler Thromb Vasc Biol</source><year>2012</year><volume>32</volume><fpage>223</fpage><lpage>9</lpage><comment>doi: 10.1161/ATVBAHA.111.236927</comment><pub-id pub-id-type="pmid">22095980</pub-id></element-citation></ref><ref id="ref68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hofmann Bowman</surname><given-names>MA</given-names></name><name><surname>Gawdzik</surname><given-names>J</given-names></name><name><surname>Bukhari</surname><given-names>U</given-names></name><name><surname>Husain</surname><given-names>AN</given-names></name><name><surname>Toth</surname><given-names>PT</given-names></name><name><surname>Kim</surname><given-names>G</given-names></name><etal/></person-group><article-title>S100A12 in vascular smooth muscle accelerates vascular calcification in apolipoprotein E-null mice by activating an osteogenic gene regulatory program</article-title><source>Arterioscler Thromb Vasc Biol</source><year>2011</year><volume>31</volume><fpage>337</fpage><lpage>44</lpage><comment>doi: 10.1161/ATVBAHA.110.217745</comment><pub-id pub-id-type="pmid">20966394</pub-id></element-citation></ref><ref id="ref69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gawdzik</surname><given-names>J</given-names></name><name><surname>Mathew</surname><given-names>L</given-names></name><name><surname>Kim</surname><given-names>G</given-names></name><name><surname>Puri</surname><given-names>TS</given-names></name><name><surname>Hofmann Bowman</surname><given-names>MA</given-names></name></person-group><article-title>Vascular remodeling and arterial calcification are directly mediated by S100A12 (EN-RAGE) in chronic kidney disease</article-title><source>Am J Nephrol</source><year>2011</year><volume>33</volume><fpage>250</fpage><lpage>9</lpage><comment>doi: 10.1159/000324693</comment><pub-id pub-id-type="pmid">21372560</pub-id></element-citation></ref><ref id="ref70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berthier</surname><given-names>S</given-names></name><name><surname>Paclet</surname><given-names>MH</given-names></name><name><surname>Lerouge</surname><given-names>S</given-names></name><name><surname>Roux</surname><given-names>F</given-names></name><name><surname>Vergnaud</surname><given-names>S</given-names></name><name><surname>Coleman</surname><given-names>AW</given-names></name><etal/></person-group><article-title>Changing the conformation state of cytochrome b558 initiates NADPH oxidase activation: MRP8/MRP14 regulation</article-title><source>J Biol Chem</source><year>2003</year><volume>278</volume><fpage>25499</fpage><lpage>508</lpage><comment>doi: 10.1074/jbc.M209755200</comment><pub-id pub-id-type="pmid">12719414</pub-id></element-citation></ref><ref id="ref71"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Byon</surname><given-names>CH</given-names></name><name><surname>Javed</surname><given-names>A</given-names></name><name><surname>Dai</surname><given-names>Q</given-names></name><name><surname>Kappes</surname><given-names>JC</given-names></name><name><surname>Clemens</surname><given-names>TL</given-names></name><name><surname>Darley-Usmar</surname><given-names>VM</given-names></name><etal/></person-group><article-title>Oxidative stress induces vascular calcification through modulation of the osteogenic transcription factor Runx2 by AKT signaling</article-title><source>J Biol Chem</source><year>2008</year><volume>283</volume><fpage>15319</fpage><lpage>27</lpage><comment>doi: 10.1074/jbc.M800021200</comment><pub-id pub-id-type="pmid">18378684</pub-id></element-citation></ref><ref id="ref72"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Das</surname><given-names>D</given-names></name><name><surname>Gawdzik</surname><given-names>J</given-names></name><name><surname>Dellefave-Castillo</surname><given-names>L</given-names></name><name><surname>McNally</surname><given-names>EM</given-names></name><name><surname>Husain</surname><given-names>A</given-names></name><name><surname>Raman</surname><given-names>J</given-names></name><etal/></person-group><article-title>S100A12 expression in thoracic aortic aneurysm is associated with increased risk of dissection and perioperative complications</article-title><source>J Am Coll Cardiol</source><year>2012</year><volume>60</volume><fpage>775</fpage><lpage>85</lpage><comment>doi: 10.1016/j.jacc.2012.04.027</comment><pub-id pub-id-type="pmid">22818064</pub-id></element-citation></ref><ref id="ref73"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bostr&#x000f6;m</surname><given-names>K</given-names></name><name><surname>Tsao</surname><given-names>D</given-names></name><name><surname>Shen</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Demer</surname><given-names>LL</given-names></name></person-group><article-title>Matrix GLA protein modulates differentiation induced by bone morphogenetic protein-2 in C3H10T1/2 cells</article-title><source>J Biol Chem</source><year>2001</year><volume>276</volume><fpage>14044</fpage><lpage>52</lpage><comment>doi: 10.1074/jbc.M008103200</comment><pub-id pub-id-type="pmid">11278388</pub-id></element-citation></ref><ref id="ref74"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zebboudj</surname><given-names>AF</given-names></name><name><surname>Imura</surname><given-names>M</given-names></name><name><surname>Bostr&#x000f6;m</surname><given-names>K</given-names></name></person-group><article-title>Matrix GLA protein, a regulatory protein for bone morphogenetic protein-2</article-title><source>J Biol Chem</source><year>2002</year><volume>277</volume><fpage>4388</fpage><lpage>94</lpage><comment>doi: 10.1074/jbc.M109683200</comment><pub-id pub-id-type="pmid">11741887</pub-id></element-citation></ref><ref id="ref75"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newman</surname><given-names>B</given-names></name><name><surname>Gigout</surname><given-names>LI</given-names></name><name><surname>Sudre</surname><given-names>L</given-names></name><name><surname>Grant</surname><given-names>ME</given-names></name><name><surname>Wallis</surname><given-names>GA</given-names></name></person-group><article-title>Coordinated expression of matrix Gla protein is required during endochondral ossification for chondrocyte survival</article-title><source>J Cell Biol</source><year>2001</year><volume>154</volume><fpage>659</fpage><lpage>66</lpage><comment>doi: 10.1083/jcb.200106040</comment><pub-id pub-id-type="pmid">11489922</pub-id></element-citation></ref><ref id="ref76"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wallin</surname><given-names>R</given-names></name><name><surname>Cain</surname><given-names>D</given-names></name><name><surname>Hutson</surname><given-names>SM</given-names></name><name><surname>Sane</surname><given-names>DC</given-names></name><name><surname>Loeser</surname><given-names>R</given-names></name></person-group><article-title>Modulation of the binding of matrix Gla protein (MGP) to bone morphogenetic protein-2 (BMP-2)</article-title><source>Thromb Haemost</source><year>2000</year><volume>84</volume><fpage>1039</fpage><lpage>44</lpage><pub-id pub-id-type="pmid">11154111</pub-id></element-citation></ref><ref id="ref77"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schurgers</surname><given-names>LJ</given-names></name><name><surname>Teunissen</surname><given-names>KJ</given-names></name><name><surname>Knapen</surname><given-names>MH</given-names></name><name><surname>Kwaijtaal</surname><given-names>M</given-names></name><name><surname>van Diest</surname><given-names>R</given-names></name><name><surname>Appels</surname><given-names>A</given-names></name><etal/></person-group><article-title>Novel conformation-specific antibodies against matrix gamma-carboxyglutamic acid (Gla) protein: Undercarboxylated matrix Gla protein as marker for vascular calcification</article-title><source>Arterioscler Thromb Vasc Biol</source><year>2005</year><volume>25</volume><fpage>1629</fpage><lpage>33</lpage><comment>doi: 10.1161/01.ATV.0000173313.46222.43</comment><pub-id pub-id-type="pmid">15961706</pub-id></element-citation></ref><ref id="ref78"><label>78</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heiss</surname><given-names>A</given-names></name><name><surname>DuChesne</surname><given-names>A</given-names></name><name><surname>Denecke</surname><given-names>B</given-names></name><name><surname>Gr&#x000f6;tzinger</surname><given-names>J</given-names></name><name><surname>Yamamoto</surname><given-names>K</given-names></name><name><surname>Renn&#x000e9;</surname><given-names>T</given-names></name><etal/></person-group><article-title>Structural basis of calcification inhibition by alpha 2-HS glycoprotein/fetuin-A. Formation of colloidal calciprotein particles</article-title><source>J Biol Chem</source><year>2003</year><volume>278</volume><fpage>13333</fpage><lpage>41</lpage><comment>doi: 10.1074/jbc.M210868200</comment><pub-id pub-id-type="pmid">12556469</pub-id></element-citation></ref><ref id="ref79"><label>79</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname><given-names>XH</given-names></name><name><surname>Zhao</surname><given-names>LL</given-names></name><name><surname>Yuan</surname><given-names>LQ</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Xie</surname><given-names>H</given-names></name><name><surname>Liao</surname><given-names>EY</given-names></name></person-group><article-title>Development of arterial calcification in adiponectin-deficient mice: Adiponectin regulates arterial calcification</article-title><source>J Bone Miner Res</source><year>2009</year><volume>24</volume><fpage>1461</fpage><lpage>8</lpage><comment>doi: 10.1359/jbmr.090227</comment><pub-id pub-id-type="pmid">19257834</pub-id></element-citation></ref><ref id="ref80"><label>80</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liabeuf</surname><given-names>S</given-names></name><name><surname>Desjardins</surname><given-names>L</given-names></name><name><surname>Diouf</surname><given-names>M</given-names></name><name><surname>Temmar</surname><given-names>M</given-names></name><name><surname>Renard</surname><given-names>C</given-names></name><name><surname>Choukroun</surname><given-names>G</given-names></name><etal/></person-group><article-title>The addition of vascular calcification scores to traditional risk factors improves cardiovascular risk assessment in patients with chronic kidney disease</article-title><source>PLoS One</source><year>2015</year><volume>10</volume><fpage>e0131707</fpage><comment>doi: 10.1371/journal.pone.0131707</comment><pub-id pub-id-type="pmid">26181592</pub-id></element-citation></ref><ref id="ref81"><label>81</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raggi</surname><given-names>P</given-names></name><name><surname>Bellasi</surname><given-names>A</given-names></name></person-group><article-title>Clinical assessment of vascular calcification</article-title><source>Adv Chronic Kidney Dis</source><year>2007</year><volume>14</volume><fpage>37</fpage><lpage>43</lpage><comment>doi: 10.1053/j.ackd.2006.10.006</comment><pub-id pub-id-type="pmid">17200042</pub-id></element-citation></ref><ref id="ref82"><label>82</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Komatsu</surname><given-names>M</given-names></name><name><surname>Okazaki</surname><given-names>M</given-names></name><name><surname>Tsuchiya</surname><given-names>K</given-names></name><name><surname>Kawaguchi</surname><given-names>H</given-names></name><name><surname>Nitta</surname><given-names>K</given-names></name></person-group><article-title>Aortic arch calcification predicts cardiovascular and all-cause mortality in maintenance hemodialysis patients</article-title><source>Kidney Blood Press Res</source><year>2014</year><volume>39</volume><fpage>658</fpage><lpage>67</lpage><comment>doi: 10.1159/000368476</comment><pub-id pub-id-type="pmid">25571879</pub-id></element-citation></ref><ref id="ref83"><label>83</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>London</surname><given-names>GM</given-names></name><name><surname>Gu&#x000e9;rin</surname><given-names>AP</given-names></name><name><surname>Marchais</surname><given-names>SJ</given-names></name><name><surname>M&#x000e9;tivier</surname><given-names>F</given-names></name><name><surname>Pannier</surname><given-names>B</given-names></name><name><surname>Adda</surname><given-names>H</given-names></name></person-group><article-title>Arterial media calcification in end-stage renal disease: Impact on all-cause and cardiovascular mortality</article-title><source>Nephrol Dial Transplant</source><year>2003</year><volume>18</volume><fpage>1731</fpage><lpage>40</lpage><comment>doi: 10.1093/ndt/gfg414</comment><pub-id pub-id-type="pmid">12937218</pub-id></element-citation></ref><ref id="ref84"><label>84</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yeluri</surname><given-names>G</given-names></name><name><surname>Kumar</surname><given-names>CA</given-names></name><name><surname>Raghav</surname><given-names>N</given-names></name></person-group><article-title>Correlation of dental pulp stones, carotid artery and renal calcifications using digital panoramic radiography and ultrasonography</article-title><source>Contemp Clin Dent</source><year>2015</year><volume>6</volume><issue>Suppl 1</issue><fpage>S147</fpage><lpage>51</lpage><comment>doi: 10.4103/0976-237X.166837</comment><pub-id pub-id-type="pmid">26604565</pub-id></element-citation></ref><ref id="ref85"><label>85</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benedetto</surname><given-names>FA</given-names></name><name><surname>Mallamaci</surname><given-names>F</given-names></name><name><surname>Tripepi</surname><given-names>G</given-names></name><name><surname>Zoccali</surname><given-names>C</given-names></name></person-group><article-title>Prognostic value of ultrasonographic measurement of carotid intima media thickness in dialysis patients</article-title><source>J Am Soc Nephrol</source><year>2001</year><volume>12</volume><fpage>2458</fpage><lpage>64</lpage><pub-id pub-id-type="pmid">11675423</pub-id></element-citation></ref><ref id="ref86"><label>86</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guedes</surname><given-names>MM</given-names></name><name><surname>Botelho</surname><given-names>C</given-names></name><name><surname>Maia</surname><given-names>P</given-names></name><name><surname>Ibeas</surname><given-names>J</given-names></name><name><surname>Ponce</surname><given-names>P</given-names></name></person-group><article-title>Doppler ultrasound and calcification score: Improving vascular access surveillance</article-title><source>Ren Fail</source><year>2015</year><volume>37</volume><fpage>1425</fpage><lpage>9</lpage><comment>doi: 10.3109/0886022X.2015.1077316</comment><pub-id pub-id-type="pmid">26336882</pub-id></element-citation></ref><ref id="ref87"><label>87</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van der Bijl</surname><given-names>N</given-names></name><name><surname>Joemai</surname><given-names>RM</given-names></name><name><surname>Geleijns</surname><given-names>J</given-names></name><name><surname>Bax</surname><given-names>JJ</given-names></name><name><surname>Schuijf</surname><given-names>JD</given-names></name><name><surname>de Roos</surname><given-names>A</given-names></name><etal/></person-group><article-title>Assessment of Agatston coronary artery calcium score using contrast-enhanced CT coronary angiography</article-title><source>AJR Am J Roentgenol</source><year>2010</year><volume>195</volume><fpage>1299</fpage><lpage>305</lpage><comment>doi: 10.2214/AJR.09.3734</comment><pub-id pub-id-type="pmid">21098187</pub-id></element-citation></ref><ref id="ref88"><label>88</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agatston</surname><given-names>AS</given-names></name><name><surname>Janowitz</surname><given-names>WR</given-names></name><name><surname>Hildner</surname><given-names>FJ</given-names></name><name><surname>Zusmer</surname><given-names>NR</given-names></name><name><surname>Viamonte</surname><given-names>M</given-names><suffix>Jr</suffix></name><name><surname>Detrano</surname><given-names>R</given-names></name></person-group><article-title>Quantification of coronary artery calcium using ultrafast computed tomography</article-title><source>J Am Coll Cardiol</source><year>1990</year><volume>15</volume><fpage>827</fpage><lpage>32</lpage><comment>doi: 10.1016/0735-1097(90)90282-T</comment><pub-id pub-id-type="pmid">2407762</pub-id></element-citation></ref><ref id="ref89"><label>89</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mautner</surname><given-names>GC</given-names></name><name><surname>Mautner</surname><given-names>SL</given-names></name><name><surname>Froehlich</surname><given-names>J</given-names></name><name><surname>Feuerstein</surname><given-names>IM</given-names></name><name><surname>Proschan</surname><given-names>MA</given-names></name><name><surname>Roberts</surname><given-names>WC</given-names></name><etal/></person-group><article-title>Coronary artery calcification: Assessment with electron beam CT and histomorphometric correlation</article-title><source>Radiology</source><year>1994</year><volume>192</volume><fpage>619</fpage><lpage>23</lpage><comment>doi: 10.1148/radiology.192.3.8058924</comment><pub-id pub-id-type="pmid">8058924</pub-id></element-citation></ref><ref id="ref90"><label>90</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rumberger</surname><given-names>JA</given-names></name><name><surname>Simons</surname><given-names>DB</given-names></name><name><surname>Fitzpatrick</surname><given-names>LA</given-names></name><name><surname>Sheedy</surname><given-names>PF</given-names></name><name><surname>Schwartz</surname><given-names>RS</given-names></name></person-group><article-title>Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area. A histopathologic correlative study</article-title><source>Circulation</source><year>1995</year><volume>92</volume><fpage>2157</fpage><lpage>62</lpage><comment>doi: 10.1161/01.CIR.92.8.2157</comment><pub-id pub-id-type="pmid">7554196</pub-id></element-citation></ref><ref id="ref91"><label>91</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Polonsky</surname><given-names>TS</given-names></name><name><surname>McClelland</surname><given-names>RL</given-names></name><name><surname>Jorgensen</surname><given-names>NW</given-names></name><name><surname>Bild</surname><given-names>DE</given-names></name><name><surname>Burke</surname><given-names>GL</given-names></name><name><surname>Guerci</surname><given-names>AD</given-names></name><etal/></person-group><article-title>Coronary artery calcium score and risk classification for coronary heart disease prediction</article-title><source>JAMA</source><year>2010</year><volume>303</volume><fpage>1610</fpage><lpage>6</lpage><comment>doi: 10.1001/jama.2010.461</comment><pub-id pub-id-type="pmid">20424251</pub-id></element-citation></ref><ref id="ref92"><label>92</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>RK</given-names></name><name><surname>Sharma</surname><given-names>RK</given-names></name><name><surname>Voelker</surname><given-names>DJ</given-names></name><name><surname>Singh</surname><given-names>VN</given-names></name><name><surname>Pahuja</surname><given-names>D</given-names></name><name><surname>Nash</surname><given-names>T</given-names></name><etal/></person-group><article-title>Cardiac risk stratification: Role of the coronary calcium score</article-title><source>Vasc Health Risk Manag</source><year>2010</year><volume>6</volume><fpage>603</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">20730016</pub-id></element-citation></ref><ref id="ref93"><label>93</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Azevedo</surname><given-names>CF</given-names></name><name><surname>Rochitte</surname><given-names>CE</given-names></name><name><surname>Lima</surname><given-names>JA</given-names></name></person-group><article-title>Coronary artery calcium score and coronary computed tomographic angiography for cardiovascular risk stratification</article-title><source>Arq Bras Cardiol</source><year>2012</year><volume>98</volume><fpage>559</fpage><lpage>68</lpage><comment>doi: 10.1590/S0066-782X2012000600012</comment><pub-id pub-id-type="pmid">22892694</pub-id></element-citation></ref><ref id="ref94"><label>94</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greenland</surname><given-names>P</given-names></name><name><surname>Alpert</surname><given-names>JS</given-names></name><name><surname>Beller</surname><given-names>GA</given-names></name><name><surname>Benjamin</surname><given-names>EJ</given-names></name><name><surname>Budoff</surname><given-names>MJ</given-names></name><name><surname>Fayad</surname><given-names>ZA</given-names></name><etal/></person-group><article-title>2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines</article-title><source>Circulation</source><year>2010</year><volume>122</volume><fpage>e584</fpage><lpage>636</lpage><comment>doi: 10.1161/CIR.0b013e3182051b4c</comment><pub-id pub-id-type="pmid">21098428</pub-id></element-citation></ref><ref id="ref95"><label>95</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Neill</surname><given-names>WC</given-names></name><name><surname>Lomashvili</surname><given-names>KA</given-names></name></person-group><article-title>Recent progress in the treatment of vascular calcification</article-title><source>Kidney Int</source><year>2010</year><volume>78</volume><fpage>1232</fpage><lpage>9</lpage><comment>doi: 10.1038/ki.2010.334</comment><pub-id pub-id-type="pmid">20861819</pub-id></element-citation></ref><ref id="ref96"><label>96</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>M</given-names></name><name><surname>Rementer</surname><given-names>C</given-names></name><name><surname>Giachelli</surname><given-names>CM</given-names></name></person-group><article-title>Vascular calcification: An update on mechanisms and challenges in treatment</article-title><source>Calcif Tissue Int</source><year>2013</year><volume>93</volume><fpage>365</fpage><lpage>73</lpage><comment>doi: 10.1007/s00223-013-9712-z</comment><pub-id pub-id-type="pmid">23456027</pub-id></element-citation></ref></ref-list></back></article>